Allogene Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
210 East Grand Avenue, South San Francisco, CA
Fiscal year end
December 31
Data updated at
11/7/2024, 04:16 PM
Form type Sec Links Description Filing date Reporting date
SC 13G Report Nov 4, 2024
SC 13G/A Report Oct 22, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 14, 2024
SC 13G/A Report SCHEDULE 13G/A Feb 13, 2024
SC 13G/A Report Feb 9, 2024
SC 13G/A Report Jan 29, 2024
SC 13G/A Report Jan 23, 2024
SC 13G Report Jul 10, 2023
SC 13G Report SC 13G Feb 13, 2023
SC 13G/A Report SC 13G/A Feb 13, 2023
SC 13G Report SCHEDULE 13G Feb 9, 2023
SC 13G Report Feb 3, 2023
SC 13G Report Feb 3, 2023
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report SEC SCHEDULE 13G Feb 11, 2022
SC 13G/A Report SEC SCHEDULE 13G Feb 11, 2022
SC 13G/A Report Feb 10, 2022
SC 13G Report SEC SCHEDULE 13G Feb 16, 2021
SC 13G/A Report SEC SCHEDULE 13G Feb 16, 2021
SC 13G/A Report SC 13G/A Feb 12, 2021
SC 13G/A Report SC 13G/A Feb 12, 2021
SC 13G Report SC 13G Feb 14, 2020
SC 13G/A Report SC 13G/A Feb 13, 2020
SC 13G/A Report SC 13G/A Feb 13, 2020
SC 13G Report SC 13G Feb 13, 2019
SC 13G Report SC 13G Feb 13, 2019
SC 13G Report SC 13G Feb 13, 2019